The US Food and Drug Administration (FDA) has approved Pfizer and BioNTech’s mRNA COVID-19 vaccine, Comirnaty, for people 16 years or older. The announcement represents not just the first approved ...
Ron Johnson (R-Wis.) released the FDA analysis on pediatric deaths tied to COVID shots that was touted by former FDA ...
Vinay Prasad, a top regulator at the FDA, did not detail the data in the internal memo that led to the conclusion Pfizer and BioNTech developed the COVID-19 vaccine Comirnaty. Shares of Moderna and ...
The Palladium-Item on MSN
Here's what to know about the FDA's COVID-19 vaccine changes
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
As fall approaches and COVID cases tick up, you might be thinking about getting this season’s COVID-19 vaccine. The annually updated shots have previously been easily accessible to anyone over 6 ...
If you’re unsure whether you can get a COVID-19 vaccine, you’re not alone. This year, the guidance has shifted. Instead of a simple “everyone should get it,” the CDC now recommends a more personalized ...
The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them. Approval of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results